Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

26 Nov 2018 Evaluate

Alembic Pharmaceuticals has informed that the company's joint venture, Aleor Dermaceuticals, has received United States Food and Drugs Administration (USFDA) Approval for Lidocaine Ointment USP, 5%. Further, the company has submitted the press release.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..